Live from NPR News in Washington on Core of a Coleman, the World Health Organ...
the Ebola outbreak in Democratic Republic of the Congo is spreading.
“The WHO's Director General Tedros Adnaham Gebraiasis says it is moving rapidly, so the”
UN Health Agency is changing its risk evaluation. Previously, WHO accessed the risk as high as the national and regional levels in low at global levels. We are now devising our risk assessment to very high at the national level, high at the regional level, and low at global level. So far there are 82 confirmed cases and 7 confirmed deaths, but Tedros says there are
more than 750 suspected Ebola cases and more suspected cases could be identified. Pakistan's Interior Minister has been holding meetings with Iranian officials this week
in Tehran. He's trying to hammer out a deal with the U.S. and Iran.
It comes as President Trump says he's willing to give Iran more time for deciding whether to resume the war. And beer's Ayah Betrowe reports. Iranian media report there are various interim proposals being discussed in Tehran, including
“one backed by China. The key issue is Iran's control of the state of Hermuz since the”
start of the U.S. is really war three months ago. Iran established a new authority to approve and collect tolls from ships that want to transit the strategic waterway. Secretary of State Marco Rubio told reporters a toll system can't happen. "You can't happen. It would be unacceptable. It would make a diplomatic deal unfeasible if they were to continue to pursue that."
The Trump administration wants Iran to store its enriched uranium abroad and posits nuclear program. Iran has signaled those are red lines, an insist on a permanent ceasefire that lifts U.S. sanctions. Ayah Betrowe and Pernus, Dubai. President Trump has apparently changed his mind and will deploy 5,000 U.S. troops to Poland. This comes after he said he would pull 5,000 troops from Germany.
“Writing on the line, Trump suggested this is coming after Poland shows a conservative”
nationalist as its new president last year. The Democratic National Committee has released a post-mortem of its 20-24 election defeats. But as NPR Steven Fowler reports, the party does not stand behind the unfinished report or its conclusions. "Diansy Chair Ken Martin received the 2024 autopsy late last year and announced he wouldn't publish it, opting instead to focus on the party's victories in recent elections.
Now, he's apologizing and has made the 192-page document public. The report titled "Build to win. Build to last is incomplete. Didn't include any source documents or data to verify its claims and is not something the party stands by," Martin said. The disconnect with a DNC comes as voters have record low approval of the Democratic Party, but continued to vote for Democratic candidates in large numbers. Steven Fowler, NPR News.
"You're listening to NPR News from Washington. The state of Tennessee attempted to conduct an execution yesterday and failed. Authorities were attempting to put convicted murderer Tony Carothers to Death by lethal injection. Executioners were unable to establish an IV line after an hour of trying. Tennessee Governor Bill Lee says the state will not attempt the execution again for at least a year."
Drugmaker Eli Lilly is studying next-generation obesity drug. It's not available for sale yet. New study results show. It helped people lose more weight than the obesity injections and drugs already available. NPR Sydney Love can reports. Eli Lilly is researching retitutied. Unlike Wagovi and Zepbound, which target the GLP-1 hormone, this new drug works on three hormones. GLP-1, GIP, and Glucagon. The company says that in the clinical trial, people taking it for 80 weeks
lost an average of more than 70 pounds at the highest dose. That's compared with five and a half pounds for the patients taking up placebo over the same time period. And people taking Eli Lilly's experimental drug lost more weight than people taking Zepbound or Wagovi over a similar time period in other studies. Common side effects were similar to other GLP-1 drugs, including nausea and other gastrointestinal issues. Eli Lilly has not yet submitted retitutied for food and
drug administration approval. Sydney Love can and PR news. Thousands of people remain evacuated north of Los Angeles as the sandy wildfire continues to burn in Southern California. Authority say
the wildfire is about 40 percent contained. I'm Corva Coleman, NPR News. News shows new music, new
movies, keeping up with pop culture sometimes feels like a full-time job. Thankfully, over at pop culture happy-hour, it's literally our job. We break down what's actually worth watching, listening to and pretending you already knew about. So the next time someone says, "Did you see that?" You can say, yeah, obviously, follow NPR's pop culture happy-hour wherever you get your podcasts.
